Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

AGL

Angle (AGL)

Angle Plc
Date:
Sort by:
 Showing the most relevant articles for your search:LSE:AGL
DateTimeSourceHeadlineSymbolCompany
07/18/20244:08AMRNS Regulatory NewsAngle PLC Standard form for notification of major holdingsLSE:AGLAngle Plc
07/12/20249:38AMRNS Regulatory NewsAngle PLC Standard form for notification of major holdingsLSE:AGLAngle Plc
07/11/20249:07AMRNS Regulatory NewsAngle PLC Result of 2024 Annual General MeetingLSE:AGLAngle Plc
06/21/20244:52AMAlliance NewsAlliance NewsIN BRIEF: Angle says open offer raises proceeds of GBP500,000LSE:AGLAngle Plc
06/21/20241:00AMRNS Regulatory NewsAngle PLC Result of open offerLSE:AGLAngle Plc
06/18/20248:41AMRNS Regulatory NewsAngle PLC Posting of 2023 Annual Report & Notice of the AGMLSE:AGLAngle Plc
06/11/20241:00AMRNS Non-RegulatoryAngle PLC Parsortix and assays being showcased at EACR 2024LSE:AGLAngle Plc
06/06/202410:37AMRNS Regulatory NewsAngle PLC Publication of CircularLSE:AGLAngle Plc
06/05/202410:32AMAlliance NewsAlliance NewsEARNINGS AND TRADING: STV sees advertising upturn; Angle loss narrowsLSE:AGLAngle Plc
06/05/202410:04AMRNS Regulatory NewsAngle PLC Results of placing and subscriptionLSE:AGLAngle Plc
06/05/20241:00AMRNS Regulatory NewsAngle PLC Proposed Placing, Subscription and Open OfferLSE:AGLAngle Plc
06/05/20241:00AMRNS Regulatory NewsAngle PLC Preliminary ResultsLSE:AGLAngle Plc
05/16/20242:09PMAlliance NewsAlliance NewsTRADING UPDATES: Bens Creek considers administration; Nexxen inks dealLSE:AGLAngle Plc
05/16/20241:00AMRNS Non-RegulatoryAngle PLC Study of ovarian cancer CTCs using ParsortixLSE:AGLAngle Plc
05/03/20246:17AMAlliance NewsAlliance NewsCORRECT: Angle shares up on assay development deal with AstraZenecaLSE:AGLAngle Plc
05/03/20245:50AMAlliance NewsAlliance NewsAngle shares up on assay development deal with AstraZenacaLSE:AGLAngle Plc
05/03/20241:00AMRNS Regulatory NewsAngle PLC New commercial agreement with large pharmaLSE:AGLAngle Plc
04/24/20244:32AMAlliance NewsAlliance NewsAngle shares jump on supplier agreement with with AstraZenecaLSE:AGLAngle Plc
04/24/20241:00AMRNS Regulatory NewsAngle PLC New commercial agreement with AstraZenecaLSE:AGLAngle Plc
04/22/202410:52AMAlliance NewsAlliance NewsIN BRIEF: Angle granted patents in US and Europe for Cellkeep slideLSE:AGLAngle Plc
04/22/20241:00AMRNS Regulatory NewsAngle PLC US and EU patents for innovative CellKeep™ slideLSE:AGLAngle Plc
04/08/20241:00AMRNS Non-RegulatoryAngle PLC Parsortix HER2 assay showcased at AACR 2024LSE:AGLAngle Plc
03/22/20242:00AMRNS Non-RegulatoryAngle PLC Parsortix at European breast cancer conferenceLSE:AGLAngle Plc
01/22/202412:03PMAlliance NewsAlliance NewsIN BRIEF: Angle highlights supportive data for DNA analysis toolLSE:AGLAngle Plc
01/22/20241:00AMRNS Non-RegulatoryAngle PLC Potential utility in precision oncologyLSE:AGLAngle Plc
01/10/20246:57AMUK RegulatoryAngle PLC Standard form for notification of major holdingsLSE:AGLAngle Plc
01/04/20246:19AMAlliance NewsAlliance NewsAngle shares soar following "breakthrough" cancer diagnostics resultsLSE:AGLAngle Plc
01/04/20243:10AMDow Jones NewsAngle PLC Shares Rise on Cancer Patient Blood Sample AnalysisLSE:AGLAngle Plc
01/04/20241:00AMUK RegulatoryAngle PLC Breakthrough clinical resultsLSE:AGLAngle Plc
01/02/20242:51AMAlliance NewsAlliance NewsIN BRIEF: Angle teams with Japan's Eisai in breast cancer drug trialLSE:AGLAngle Plc
 Showing the most relevant articles for your search:LSE:AGL

Your Recent History

Delayed Upgrade Clock